Rare diseases
Investigational molecules
Locations
Back to Germany111 clinical trials in Bad Bentheim, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis
GermanyLong-term Safety and Efficacy of ORKA-001 in Adults with Moderate-to-Severe Plaque Psoriasis (Open-Label Extension Study)
GermanySafety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne
GermanyLong-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis
GermanyA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
GermanyStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis
GermanyA Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus
GermanyA study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
GermanyStudy to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis
GermanyORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
GermanyA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on plaque psoriasis and psoriatic arthritis are evaluating novel therapeutic approaches. Research includes comparative studies of new biological treatments and long-term safety assessments.
These studies aim to improve treatment outcomes for patients with varying severities of psoriatic conditions.
Innovative clinical trials are investigating treatments for atopic dermatitis and chronic hand eczema. Studies range from evaluating new biological therapies to investigating dose optimization strategies.
Research focuses on both adult and adolescent populations, with emphasis on long-term efficacy and safety.
Research initiatives addressing various dermatological conditions, including hidradenitis suppurativa, prurigo nodularis, and actinic keratosis. Novel therapeutic approaches are being tested.
These trials aim to develop targeted treatments for challenging skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
